c3056f767204679585eca2b5b4cacba1

PRECICONTROL HIV; HIV-2+GRPO

ROCHE DIAGNOSTICS GMBH (FABRICANTE PRODUCTO TERMINADO)·III·Colombia INVIMA·Expires March 01, 2028

Device classification

Risk class / Clase de Riesgo: III
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: c3056f767204679585eca2b5b4cacba1
Expire date: March 01, 2028

Authorized company / Fabricante

Name (Spanish): ROCHE DIAGNOSTICS GMBH (FABRICANTE PRODUCTO TERMINADO)
Name (English): ROCHE DIAGNOSTICS GMBH (FINISHED PRODUCT MANUFACTURER)

Product use / Uso del Producto

Spanish

PRECICONTROL HIV; HIV-2+ GRPO SIRVE PARA EL CONTROL DE CALIDAD DE LOS INMUNOANÁLISIS ELECSYS HIV COMBI PT Y ELECSYS HIV DUO EN LOS INMUNOANALIZADORES ELECSYS Y COBAS E.

English

PRECICONTROL HIV; HIV-2+ GRPO SERVES FOR CONTROL QUALITY OF ELECSYS HIV IMMUNOASSAY COMBI PT AND ELECSYS HIV DUO IN THE ELECSYS AND COBAS IMMUNOANALYZERS E.

About this record

Access comprehensive regulatory information for PRECICONTROL HIV; HIV-2+GRPO (PRECICONTROL HIV; HIV-2+GRPO) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID c3056f767204679585eca2b5b4cacba1 and manufactured by ROCHE DIAGNOSTICS GMBH (FABRICANTE PRODUCTO TERMINADO). The device was registered on March 01, 2028.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.